1-5864475-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.

The NM_015102.5(NPHP4):​c.3859C>G​(p.Gln1287Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000493 in 1,600,666 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 1 hom. )

Consequence

NPHP4
NM_015102.5 missense

Scores

1
10
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 7.62

Publications

3 publications found
Variant links:
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
  • nephronophthisis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Senior-Loken syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHP4NM_015102.5 linkc.3859C>G p.Gln1287Glu missense_variant Exon 28 of 30 ENST00000378156.9 NP_055917.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHP4ENST00000378156.9 linkc.3859C>G p.Gln1287Glu missense_variant Exon 28 of 30 1 NM_015102.5 ENSP00000367398.4 O75161-1
NPHP4ENST00000378169.7 linkn.*2760C>G non_coding_transcript_exon_variant Exon 25 of 27 1 ENSP00000367411.3 D6RA06
NPHP4ENST00000489180.6 linkn.*1670C>G non_coding_transcript_exon_variant Exon 31 of 33 2 ENSP00000423747.1 O75161-2
NPHP4ENST00000378169.7 linkn.*2760C>G 3_prime_UTR_variant Exon 25 of 27 1 ENSP00000367411.3 D6RA06
NPHP4ENST00000489180.6 linkn.*1670C>G 3_prime_UTR_variant Exon 31 of 33 2 ENSP00000423747.1 O75161-2

Frequencies

GnomAD3 genomes
AF:
0.000328
AC:
50
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000661
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000154
AC:
35
AN:
227196
AF XY:
0.000145
show subpopulations
Gnomad AFR exome
AF:
0.0000766
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000303
Gnomad NFE exome
AF:
0.000274
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000510
AC:
739
AN:
1448458
Hom.:
1
Cov.:
32
AF XY:
0.000485
AC XY:
349
AN XY:
719022
show subpopulations
African (AFR)
AF:
0.000151
AC:
5
AN:
33196
American (AMR)
AF:
0.0000233
AC:
1
AN:
42946
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25836
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39144
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84484
European-Finnish (FIN)
AF:
0.000173
AC:
9
AN:
52000
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.000613
AC:
678
AN:
1105346
Other (OTH)
AF:
0.000770
AC:
46
AN:
59776
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
37
74
110
147
184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000328
AC:
50
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.000350
AC XY:
26
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41462
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000661
AC:
45
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000373
Hom.:
0
Bravo
AF:
0.000249
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000723
AC:
6
ExAC
AF:
0.000108
AC:
13

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:2
Jan 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 02, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Senior-Loken syndrome 4 Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Senior-Loken syndrome 4;C1847013:Nephronophthisis 4 Uncertain:1
Feb 15, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis Uncertain:1
Oct 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 1287 of the NPHP4 protein (p.Gln1287Glu). This variant is present in population databases (rs201779243, gnomAD 0.04%). This missense change has been observed in individual(s) with retinitis pigmentosa, renal cysts and/or hearing loss (PMID: 15776426, 25472526). ClinVar contains an entry for this variant (Variation ID: 462718). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHP4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Nephronophthisis 4 Uncertain:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.064
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.32
T
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.84
T
M_CAP
Uncertain
0.11
D
MetaRNN
Uncertain
0.70
D
MetaSVM
Uncertain
0.10
D
MutationAssessor
Uncertain
2.6
M
PhyloP100
7.6
PrimateAI
Benign
0.48
T
PROVEAN
Benign
-1.4
N
REVEL
Uncertain
0.59
Sift
Benign
0.11
T
Sift4G
Uncertain
0.042
D
Polyphen
0.63
P
Vest4
0.82
MVP
0.87
MPC
0.22
ClinPred
0.13
T
GERP RS
5.2
Varity_R
0.16
gMVP
0.62
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201779243; hg19: chr1-5924535; API